Adage Capital Partners Gp, L.L.C. Regulus Therapeutics Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,000,000 shares of RGLS stock, worth $3.08 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,000,000
Previous 2,000,000
-0.0%
Holding current value
$3.08 Million
Previous $3.58 Million
12.29%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding RGLS
# of Institutions
74Shares Held
56.5MCall Options Held
79.3KPut Options Held
20.3K-
Federated Hermes, Inc. Pittsburgh, PA12.9MShares$19.8 Million0.05% of portfolio
-
Nea Management Company, LLC Timonium, MD6.47MShares$9.96 Million0.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA5MShares$7.7 Million1.15% of portfolio
-
Octagon Capital Advisors LP New York, NY4.26MShares$6.57 Million1.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.09MShares$6.3 Million0.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $22.5M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...